Graft Enhancement, Immunologic
"Graft Enhancement, Immunologic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The induction of prolonged survival and growth of allografts of either tumors or normal tissues which would ordinarily be rejected. It may be induced passively by introducing graft-specific antibodies from previously immunized donors, which bind to the graft's surface antigens, masking them from recognition by T-cells; or actively by prior immunization of the recipient with graft antigens which evoke specific antibodies and form antigen-antibody complexes which bind to the antigen receptor sites of the T-cells and block their cytotoxic activity.
| Descriptor ID |
D006082
|
| MeSH Number(s) |
E02.095.465.425.450.440 E05.478.610.500
|
| Concept/Terms |
Graft Enhancement, Immunologic- Graft Enhancement, Immunologic
- Immunologic Graft Enhancement
- Graft Enhancement, Immunological
- Enhancement, Immunological Graft
- Enhancements, Immunological Graft
- Graft Enhancements, Immunological
- Immunological Graft Enhancement
- Immunological Graft Enhancements
- Enhancement, Immunologic Graft
- Enhancements, Immunologic Graft
- Graft Enhancements, Immunologic
- Immunologic Graft Enhancements
- Immunologic Enhancement of Grafts
Graft Enhancement- Graft Enhancement
- Enhancement, Graft
- Enhancements, Graft
- Graft Enhancements
|
Below are MeSH descriptors whose meaning is more general than "Graft Enhancement, Immunologic".
Below are MeSH descriptors whose meaning is more specific than "Graft Enhancement, Immunologic".
This graph shows the total number of publications written about "Graft Enhancement, Immunologic" by people in this website by year, and whether "Graft Enhancement, Immunologic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Graft Enhancement, Immunologic" by people in Profiles.
-
Umbilical cord blood graft engineering: challenges and opportunities. Bone Marrow Transplant. 2015 Jun; 50 Suppl 2:S55-62.
-
Cord-blood engraftment with ex vivo mesenchymal-cell coculture. N Engl J Med. 2012 Dec 13; 367(24):2305-15.
-
CD40-ligand in primate cardiac allograft and viral immunity. Immunol Res. 2001; 23(2-3):253-62.
-
Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol. 1998 Aug; 16(8):2817-24.
-
Phenotypic and functional reconstitution of peripheral blood lymphocytes following T cell-depleted bone marrow transplantation from partially mismatched related donors. Bone Marrow Transplant. 1998 Mar; 21(5):461-71.
-
T-cell-depleted autologous marrow fails to prevent acute graft-versus-host disease after allogeneic marrow transplantation for lymphoblastic lymphoma. Transplant Proc. 1992 Dec; 24(6):2906-7.
-
T cell depleted bone marrow transplantation in acute myeloblastic leukaemia: the way ahead. Bone Marrow Transplant. 1989 Jan; 4 Suppl 1:225-8.
-
Evidence that pretransplant donor blood transfusion prevents rat renal allograft dysfunction but not the in situ cellular alloimmune or morphologic manifestations of rejection. Transplantation. 1988 Jan; 45(1):1-7.
-
Successful transplantation of 100 untransfused cyclosporine-treated primary recipients of cadaveric renal allografts. Transplantation. 1988 Jan; 45(1):37-40.
-
Blood transfusion experience for cyclosporine/prednisone-treated renal allograft recipients at the University of Texas Medical School at Houston. Clin Transpl. 1988; 167-70.